A Rare Primary Neuroendocrine Tumor (Typical Carcinoid) of the Sublingual Gland by Yamagata Kenji et al.
A Rare Primary Neuroendocrine Tumor (Typical
Carcinoid) of the Sublingual Gland
著者 Yamagata Kenji, Ohki Kousuke, Uchida Fumihiko,
Kanno Naomi, Hasegawa Shogo, Yanagawa Toru,
Bukawa Hiroki
journal or
publication title
Case Reports in Dentistry
volume 2016
page range 7462690
year 2016
権利 (C) 2016 Kenji Yamagata et al.
This is an open access article distributed
under the Creative Commons Attribution
License, which permits unrestricted use,
distribution, and reproduction in any medium,
provided the original work is properly cited.
URL http://hdl.handle.net/2241/00144524
doi: 10.1155/2016/7462690
Creative Commons : 表示
http://creativecommons.org/licenses/by/3.0/deed.ja
Case Report
A Rare Primary Neuroendocrine Tumor (Typical Carcinoid) of
the Sublingual Gland
Kenji Yamagata,1 Kousuke Ohki,2 Fumihiko Uchida,1 Naomi Kanno,1
Shogo Hasegawa,1 Toru Yanagawa,1 and Hiroki Bukawa1
1Department of Oral and Maxillofacial Surgery, Institute of Clinical Medicine, Faculty of Medicine,
University of Tsukuba, Tsukuba, Japan
2Department of Oral and Maxillofacial Surgery, Ishioka Daiichi Hospital, Ishioka, Japan
Correspondence should be addressed to Kenji Yamagata; y-kenji@md.tsukuba.ac.jp
Received 15 June 2016; Accepted 3 October 2016
Academic Editor: Luis M. J. Gutierrez
Copyright © 2016 Kenji Yamagata et al.This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
A typical carcinoid is extremely rare in the oral cavity. We here present a case of a typical carcinoid arising in the sublingual gland
of a 62-year-old woman.The tumor was removed by primary excision with 10mm surgical margins and submandibular dissection.
Examination of the tumor showed medium-sized tumor cells that were positive for CD56 and chromogranin A, with no necrosis,
and with a mitotic count less than 1/10 HPF. A pathological diagnosis of typical carcinoid was made from both morphological and
immunological examinations. One year after excision surgery, there was no tumor recurrence or neck metastasis.
1. Introduction
Neuroendocrine tumors (NETs) are heterogeneous, ranging
from benign to highly malignant. In the larynx, the most
frequent NETs are atypical carcinoids (53.7%), followed by
neuroendocrine-type small cell carcinomas (27.6%), paragan-
gliomas (12.1%), and typical carcinoids (6.6%) [1].The typical
carcinoid, sometimes simply referred to as a carcinoid, is a
well-differentiated neuroendocrine carcinoma (Grade I) with
sparse to absent nucleoli and mitoses [less than 2/10 high-
power fields (HPF)] and no necrosis or pleomorphism [2].
Most carcinoids occurring in the head and neck area are
found in the larynx, followed by the middle ear [3]. Yang et
al. reported the first case of a typical carcinoid in the oral
cavity in 2011 [4]. To our knowledge, only 2 cases of typical
carcinoids arising in the oral cavity have been reported [4, 5].
We here present an extremely rare case of a typical carcinoid
arising in the sublingual gland.
2. Case Report
A 62-year-old woman came to the Department of Oral
and Maxillofacial Surgery, University of Tsukuba Hospital,
with a clinical diagnosis of a sublingual gland tumor. She
had noticed swelling in the sublingual gland, with no pain,
for 9 months. She had a history of hypertension, cerebral
infarction, and hyperlipidemia. Her face was symmetrical
and there was no trismus. The regional lymph nodes were
normal, and the submandibular gland was hard and swollen.
Examination of the oral cavity showed a hard, elastic mass
measuring 28 × 13mm on the left side of the floor of her
mouth. The mucosal surface was normal, with no ulceration
(Figure 1). There was no observable saliva flow from the
opening of Wharton’s duct.
Magnetic resonance (MR) images [short TI inversion
recovery (STIR)] showed a well-defined tumor of the sub-
lingual gland with a high-signal mass measuring 28 × 25
× 12mm (Figure 2). Fluorodeoxyglucose positron emission
topography (FDG-PET) depicted a mass measuring 28 ×
13mm with a max standard uptake value (SUV) of 10.4
(Figure 3) and did not show any neck metastasis or distant
metastasis.
The carcinoid was removed by primary excision per-
formed extraorally under general anesthesia, with 10mm
surgical margins and submandibular dissection with the
level I lymph node and submandibular gland. The intraoral
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Figure 1: Intraoral examination. Examination of the oral cavity
showed a 28 × 13mm hard elastic mass in the left floor of the mouth.
The mucosal surface was normal, with no ulceration.
resected defect was partially sutured and covered with polyg-
lycolic acid (PGA) sheets and fibrin glue. The postoperative
course was uneventful. One year later, there was no tumor
recurrence or neck metastasis.
Histological examination revealed that the resected
tumor, which was 26 × 24 × 12mm, was whitish in color and
solid in consistency.The round cells were solid or arranged in
cords, trabeculae, or nests, with hyalinized stroma with high
vascularization. The tumor cells had eosinophilic cytoplasm.
The nuclei were round and varied in size, and the rough
chromatin and mitotic count was less than 1/10 HPF. There
was no necrosis (Figure 4). The tumor had partly infiltrated
the sublingual gland and had no clear boundary. Immuno-
histochemical staining showed that the tumor was CD56
(+), chromogranin A (+), and synaptophysin (−) (Figure 5).
The Ki-67 index was 2.8%. A pathological diagnosis of
typical carcinoid of the sublingual gland was made based on
the morphological and immunological exam. The surgical
margin was free, and no lymph node metastasis was found.
3. Discussion
Carcinoid tumors are the most common of the NETs. They
are usually found in the gastrointestinal tract (55%) or the
bronchopulmonary tract (10%) [6]. In 2005, WHO classified
NETs of the larynx into 4 types: (1) typical carcinoid, (2) atyp-
ical carcinoid, (3) small cell carcinoma, neuroendocrine type,
and (4) combined small cell carcinoma, neuroendocrine type,
with non-small cell carcinoma. The typical carcinoid tumor
is defined as “a tumor with a neuroendocrine/carcinoid
morphology,mitotic rate of less than 2/10HPF, and absence of
necrosis” [2]. Typical carcinoids, which are the least common
NETs in the head and neck area, occurmost commonly in the
supraglottic larynx, with rare examples in the parotid gland
and sinonasal tract. Because typical carcinoids are relatively
rare, it is still difficult to describe their clinical behavior or
prognosis [7]. The reported age at presentation ranges from
23 to 71 years, and most cases report no tumor recurrence at
follow-up (18 to 124 months after treatment) [7].
Typical carcinoids are extremely rare in the head and
neck region [8]. Only 14 NETs originating in the oral
region have been reported in the English-language literature
[9, 10]; of these, atypical carcinoid tumors were the most
Figure 2: MR images (STIR) showed a well-defined tumor of the
sublingual gland with a high-signal mass measuring 28 × 25 ×
12mm.
common (6 cases), followed by neuroendocrine- type small
cell carcinoma (4), typical carcinoids (2), and other (2). In
the 2 reported cases of typical carcinoid of the oral cavity
[4, 5], the primary sites were the mandible and retromolar
regions, and both caseswere treated by excision under general
anesthesia. In both cases, the disease did not recur during the
follow-up period (2 years in one case and 11 months in the
other) (Table 1). Although there is one report of a nontypical
carcinoid in the floor of the mouth [11], this is the first report
of a typical carcinoid arising in the floor of mouth.
Our case was diagnosed as a typical carcinoid based on
our findings and the algorithm described by Mahomed [12]
for diagnosing oral NETs. The typical carcinoid is diagnosed
based on tumor cells that are medium or large in size,
positive for epithelial and neuroendocrine markers, free of
necrosis, and having amitotic rate less than 2/10 HPF. Typical
carcinoid tumors are composed of round or spindle-shaped
cells, or both, with histologic and immunohistologic evidence
of neuroendocrine differentiation.
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Table 1: Reported cases of oral typical carcinoid.
Reference Age/gender Site Size (mm) Treatment Prognosis (M)
Coleman et al. [5] 46/F Mandible 40 × 38 × 50 Excision NED (24)
Yang et al. [4] 46/F Retromolar region 15 × 20 Excision NED (11)
Present case 62/F Floor of mouth 28 × 25 × 12 Excision NED (12)
NED: no evidence of disease.
Figure 3: FDG-PET. The sublingual mass measured 28 × 13mm and had a max SUV of 10.4.
(a) (b)
Figure 4: HE staining with low power (a) and high power (b). The round cells were arranged as cords, solids, trabeculae, and nests with a
highly vascularized, hyalinized stroma. There was no necrosis, and the mitotic count was <1/10 HPF.
(a) (b)
Figure 5: Immunohistochemical staining. The staining was positive for CD56 (a) and slightly positive for chromogranin A (b).
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According to the 2005 WHO classification of NETs of
the larynx, atypical carcinoid tumors exhibit more mitotic
and more atypical cells than do the typical carcinoids [2].
Typical carcinoid tumors are composed of round or spindle-
shaped cells that grow in trabeculae, gland-shaped structures
and/or rosettes, small nests, or large sheets. Mitosis is sparse
to absent.The stoma is highly vascularized and is often focally
fibrotic or hyalinized [2]. Immunohistochemically, NETs are
positively stained by one or more neuroendocrine markers
[12], and chromogranin A, synaptophysin, CD57, CD56,
neuron specific enolase, andneurofilaments are important for
evaluating neuroendocrine neoplasms. In the present case,
the medium-size tumor cells were positive for CD56 and
chromogranin A, had no necrosis, and had a mitotic count
less than 1/10 HPF.
Previously reported NETs have been treated by tumor
resection. Radiation and chemotherapy are ineffective against
typical carcinoids, making surgery the treatment of choice.
NETs should be resected as conservatively as possible while
still removing the tumor completely. A neck dissection is
not warranted. In the present case, the sublingual tumor
extended deeply toward the border of the mandible. The
excision was performed from the submandible extraorally
with submandibular dissection. Moreover, the patient was
in her sixth decade and was being treated surgically. The
reported rate of metastases for a carcinoid of the larynx is
33%, and the 5-year survival rate is 48% [1, 2]. In all 3 reported
cases of oral typical carcinoid, including the present case, the
carcinoid was treated by excision and did not recur during
the follow-up period (1-2 years).
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